Dr. Baiju John

Biography

I am Baiju John, residing at Galveston, USA, working as a Research Associate in University of Texas Medical Branch (from Sept 2012- ). I am involved in the fabrication of polymer linked DNA arrays based onto ITO surface and the synthesis of DNA-silane conjugate for aptamers which bind cocaine molecules. During the tenure at TOYOTA Technological Institute as a Post-Doctoral Fellow (Sept 2009- June 2012) I was closely involved in a number of projects that was funded from TOYOTA Motor Corporation. The major highlights of the work include the percolated network structure analysis of nylon 6/clay nanocomposites through rheology and computational modeling, synthesis and adsorption characteristics of hollow spherical allophane nano-particles, studies on nanocomposites hydrogels with smectite clays, preparation of polymer nanocomposites with various clay nanofillers (esp. various types of organo-montmorillonite clays with different alkyl chain lengths) and Injection molding of PA6 nanocomposites with various clay nanofillers. I worked for my Ph D with research on high performance PA6 fibers with thermoplastic polyurethane thin film coatings and polyurethane nanocomposites at Nagasaki University, JAPAN in 2009.

Research Interest

Biomaterials that are biocompatible, degradable, support tissue formation, encourage/discourage cell attachment, growth, and differentiation, provide platforms for the controlled release of growth factors, cytokines, drugs or antibiotics, and promote the formation of extracellular matrix. Biosensors based on DNA and RNA aptamers for specific molecules detection and drug delivery. Tissue engineering scaffolds for the regeneration and repair of damaged tissues and bones. ï‚· Tissue engineering constructs for delivering drugs and/or provides a platform for cell-based therapies. Molecular engineering involves designing better therapies; manipulating the operation of molecular networks and consequently cellular behavior, generating molecular devices for use in synthetic biology, and developing new molecular imaging agents that can be used to report cell processes